Skip to main content

MoneyWorks4Me

Granules India informs about press release

22 Oct 2020 Evaluate

Granules India has informed that it has enclosed the press release on 22 October 2020 titled ‘Granules India receives approval for Generic “K-Dur,” equivalent to Klor Con M, potassium chloride tablets for the treatment of Hypokalemia’. This is for the information and dissemination to the members of the exchange.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1903.00
Dr. Reddys Labs. 1398.00
Cipla 1416.00
Lupin 1999.00
Zydus Lifesciences 1200.00
View more..